Fabrication of β-glucan nanocarriers for enhanced encapsulation and delivery of doxorubicin for triple negative breast cancer treatment
Bioscience, Biotechnology, and Biochemistry · 23.07.2026 · 90 (8) · 1019-1031
DOI: 10.1093/bbb/zbag066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, online erschienen am 04.05.2026. Verfasst von Morteza Servatan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Ankara University, 06100, Ankara, Turkey. Hauptthemen laut MEDLINE: Doxorubicin, beta-Glucans, Triple Negative Breast Neoplasms, Drug Carriers. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health Institute of Turkey.
Abstract (Originalsprache)
In this study, beta glucan nanoparticles were fabricated and encapsulated with Doxorubicin for an effective drug delivery for triple negative breast cancer treatment. The synthesized nanoparticles were characterized by FTIR, TEM, SEM, DLS, and zeta potential analysis. A drug encapsulation rate of 80% was achieved and drug release studies displayed a better release of drug from encapsulated glucan nanoparticles in acidic media. In vitro cytotoxicity and cellular uptake were evaluated by MTT and fluorescence microscopy, respectively where the IC50 concentrations for Dox and Dox loaded nano glucans were found to be 2.5 and 1 µg/mL, respectively. SEM, TEM, and DLS results showed that beta glucan nanoparticles have a size distribution between 30-100 nm. FTIR and zeta potential analysis confirmed the loading of Dox. The results over MDA-MB-231 cells showed that Dox loaded beta glucan nanoparticles were effectively internalized and had more cytotoxic activity with respect to free drug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Ankara University, 06100, Ankara, Turkey.
- Biotechnology Institute, Ankara University, 06135, Ankara, Turkey.
- Department of Biology, Ankara University, 06100, Ankara, Turkey.
ORCID-Profile: Morteza Servatan, Zeynep Yilmazer Hitit, Birgütay Şahin, Suna Ertunç, Pelin Mutlu
Förderung
- Health Institute of Turkey
Zitieren
APA
Servatan, M., Bozkurt, F. Z., Hitit, Z. Y., Şahin, B., Parıltı, D. N., Ertunç, S., & Mutlu, P. (2026). Fabrication of β-glucan nanocarriers for enhanced encapsulation and delivery of doxorubicin for triple negative breast cancer treatment. Bioscience, Biotechnology, and Biochemistry, 90(8), 1019-1031. https://doi.org/10.1093/bbb/zbag066
Vancouver
Servatan M, Bozkurt FZ, Hitit ZY, Şahin B, Parıltı DN, Ertunç S, et al. Fabrication of β-glucan nanocarriers for enhanced encapsulation and delivery of doxorubicin for triple negative breast cancer treatment. Bioscience, Biotechnology, and Biochemistry. 2026;90(8):1019-1031. doi:10.1093/bbb/zbag066
BibTeX
@article{Servatan2026,
author = {Servatan, Morteza and Bozkurt, Fatma Zeynep and Hitit, Zeynep Yilmazer and Şahin, Birgütay and Parıltı, Damla Nur and Ertunç, Suna and Mutlu, Pelin},
title = {Fabrication of β-glucan nanocarriers for enhanced encapsulation and delivery of doxorubicin for triple negative breast cancer treatment},
journal = {Bioscience, Biotechnology, and Biochemistry},
year = {2026},
volume = {90},
number = {8},
pages = {1019--1031},
doi = {10.1093/bbb/zbag066}
}
EUVIMED